FDA Clearance Tracker · DEN170043
DreaMed Advisor Pro
Last checked: Nov 20, 2026Latest source record: Jun 12, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jun 12, 2018
De Novo granted
Time to decision
299 days
Received Aug 17, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN170043
- Device name
- DreaMed Advisor Pro
- Applicant
- DreaMed Diabetes, Ltd.
- Applicant location
- Petah Tikva, Pob 3271, IL
- Received
- Aug 17, 2017
- Decided
- Jun 12, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1358
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN170043
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for DreaMed Diabetes, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MODI System510(k)
K260062 · Decided Sep 8, 2026 · 243 days after receipt
Device type: Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX) · Laboratory Medicine & Pathology
- endo.digital Platform510(k)
K232722 · Decided Oct 3, 2023 · 28 days after receipt
Device type: Insulin Pump Therapy Adjustment Calculator For Healthcare Professionals (QCC) · Laboratory Medicine & Pathology
- Advisor Pro Platform510(k)
K210561 · Decided Sep 28, 2021 · 215 days after receipt
Device type: Insulin Pump Therapy Adjustment Calculator For Healthcare Professionals (QCC) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.